[
UBS Principal sold 7,40,159 lakh shares worth Rs 192 crore at a price of Rs 2,589.86 per share which was a 15% premium over the Thursday closing price of Rs 2,250.55. The stock today ended at Rs 2,591, gaining Rs 340.45 or 15.13%.
In Five-Star Business Finance, UBS Principal sold 15,80,163 shares at a price of Rs 804.74 a piece. The total sale was worth Rs 127 crore. The shares were sold at a premium of 4.4% over previous session’s closing price of Rs 770.75. The stock today settled at Rs 811, gaining by Rs 40.25 or 5.22%.
In IIFL Securities, UBS Principal sold 17,10,992 shares which were worth Rs 53 crore. The selling price was Rs 309.84 per share which was a discount of 2% over Thursday closing price of Rs 316.45. The stock settled at Rs 330 on the NSE, gaining by Rs 13.55 or 4.28%.
In Marksans Pharma UBS Principal sold 34,01,630 shares for a price of Rs 108 crore. The shares were sold at Rs 317.22 which was at a premium of 16% over Thursday’s closing price of Rs 274.44. The shares ended at Rs 327.97 on the NSE, jumping by Rs 53.53 or 19.51%. Marksans also hit a 52 week high of Rs 328.80.
Also Read: Sebi relaxes financial disincentives norms for technical glitches, restricts it to Market Infrastructure Institutions(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
https://img.etimg.com/thumb/msid-113531835,width-1200,height-630,imgsize-107306,overlay-etmarkets/photo.jpg
https://economictimes.indiatimes.com/markets/stocks/news/ubs-sells-shares-worth-rs-480-crore-in-concord-biotech-iifl-securities-2-more-stocks-via-block-deals/articleshow/113531832.cms